Brief: TScan Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million
March 5 (Reuters) - TScan Therapeutics Inc TCRX.O: TSCAN THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $300 MILLION - SEC FILING Further company coverage: TCRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing